2.12
Organovo Holdings Inc 주식(ONVO)의 최신 뉴스
Organovo (NASDAQ:ONVO) Earns Sell Rating from Analysts at StockNews.com - Defense World
Organ On A Chip Market Generated Opportunities, Future Scope - openPR.com
Organovo (ONVO) Anticipates $5M Cash Influx as Nasdaq Compliance Continues - GuruFocus
Organovo reports $11.3M cash balance in FY24 - MSN
Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements - The Manila Times
Organovo Holdings Expects to Meet Nasdaq Listing Requirements - TipRanks
Organovo expects to maintain Nasdaq listing with stable stock price By Investing.com - Investing.com Australia
Organovo expects to maintain Nasdaq listing with stable stock price - Investing.com
Organovo's Financial Update: $11.3M Cash Reserve Plus $55M Potential Milestone Payments - Stock Titan
Organovo stock plunges to 52-week low of $2.13 amid steep decline - Investing.com Canada
ONVO Stock Quote Price and Forecast - CNN
Organovo Holdings (ONVO) Sells FXR Program to Lilly (LLY), Secures Financial Future - GuruFocus
Organovo sells FXR Program, anticipates reduced costs By Investing.com - Investing.com South Africa
Organovo gets upfront payments following sale of its FXR Program to Lilly - Seeking Alpha
Organovo Provides Business Update - Quantisnow
Organovo sells FXR Program, anticipates reduced costs - Investing.com India
Organovo Holdings Completes Sale of FXR Program to Lilly - TipRanks
StockNews.com Initiates Coverage on Organovo (NASDAQ:ONVO) - Defense World
Organovo Holdings Inc Receives Upfront Payments From FXR Program Sale To Lilly - MarketScreener
Latest: Organovo Secures Future Through 2026 Following Major Lilly Partnership Deal - Stock Titan
Organovo Holdings Completes FXR Program Sale to Eli Lilly - TipRanks
Organovo Announces Close Of Sale Of FXR Program To Eli Lilly And Company - Marketscreener.com
Eli Lilly Wraps Up Acquisition of Organovo's FXR Program - Marketscreener.com
Organovo Completes Sale of FXR Program to Eli Lilly - Marketscreener.com
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company - The Manila Times
Organovo Announces Close Of The Sale Of FXR Program To Eli Lilly And Company - menafn
Major Deal: Eli Lilly Acquires Organovo's FXR Program in Strategic Asset Purchase - Stock Titan
Healthcare 3D Printing Market Demand, Growth and Future Scope - openPR.com
3D Printing in Regenerative Medicine Market Generated - openPR.com
Organovo stock hits 52-week high at $3.67 amid market fluctuations - Investing.com Australia
Organovo announces 1-for-12 reverse stock split - Investing.com India
Organovo announces 1-for-12 reverse stock split By Investing.com - Investing.com Australia
Organovo Announces 1-for-12 Reverse Stock Split To Maintain Nasdaq Compliance - Nasdaq
Dow Surges Over 200 Points; US Crude Oil Inventories Increase More than Expected - Benzinga
Nasdaq Gains Over 1%; Williams-Sonoma Shares Plunge After Q4 Results - Benzinga
Organovo announces reverse stock split; shares fall - MSN
Organovo Announces 1-for-12 Reverse Stock Split - TipRanks
Organovo Announces Reverse Stock Split - The Manila Times
Organovo Holdings, Inc. Announces 1-for-12 Reverse Stock Split Effective March 20, 2025 - Nasdaq
Organovo's Major Stock Restructuring: 1:12 Reverse Split Coming March 20 - StockTitan
Organovo (NASDAQ:ONVO) Now Covered by StockNews.com - Defense World
Matinas BioPharma Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
Matinas BioPharma Lands Organovo Chairman, Pharma Veteran in Strategic Board Revamp - StockTitan
Organovo Holdings, Inc. to Host Earnings Call - ACCESS Newswire
Organovo Announces the Issuance of Additional Shares in Conjunction with Warrant Exercises - The Manila Times
Can Organovo's $2.3M Capital Raise Fuel Its IBD Treatment Development? - StockTitan
자본화:
|
볼륨(24시간):